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In a population-based series of 2109 women with ductal carcinoma in situ (DCIS) diagnosed in 1995–2000 in New South Wales,
Australia, incidence increased by an average of 5.5% a year, mostly between 1995 and 1996 and in women 50–69 years of age. This
increase paralleled the increases in mammographic screening. BreastScreen NSW, an organised mammographic screening
programme, detected 65% of all DCIS. High-grade lesions were 54% of all lesions and were more likely to be 2þ cm in diameter
(OR¼2.12, 95%CI 1.46–3.14) than low-grade lesions. In all, 40% of DCIS in women younger than 40 years was 2þ cm in diameter
compared with 21% in women 40 years and older. Young age, high grade, mixed architecture and multifocality were significant and
independent predictors of 2þ cm DCIS.
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The epidemiology of ductal carcinoma in situ (DCIS) has yet to be
described adequately. While mammographic screening has un-
doubtedly caused increasing diagnosis of DCIS (Ernster et al, 1996,
2002; Levi et al, 1997; Barchielli et al, 1999), studies to date have
mainly been small (Levi et al, 1997; Barchielli et al, 1999) or
described populations that had no organised screening programme
(Choi et al, 1996; Ernster et al, 1996; Zheng et al, 1997).
Population-based descriptions of epidemiology and pathology of
DCIS in sizeable screened populations are nonexistent.
We describe the epidemiology and pathology of newly
diagnosed DCIS in the 2.7 million female population of New
South Wales (NSW) Australia in 1995–2000.
MATERIALS AND METHODS
Data
NSW women with a first diagnosis of DCIS in 1995–2000 and
notified to the NSW Central Cancer Registry were eligible for the
study; those with a previous or simultaneous (same month)
diagnosis of invasive breast cancer were excluded. Ductal
carcinoma in situ has been notifiable in NSW since 1993, and by
1997 all but 4% of DCIS cases diagnosed by pathology laboratories
were notified to the Cancer Registry (unpublished data).
Two experienced Cancer Registry personnel extracted informa-
tion on the type of specimen, size, grade, architecture, presence or
absence of necrosis and multifocality of DCIS, and clearance and
width of the margins from pathology reports (Kricker et al, 1999).
The frequency of mammography was obtained from reports of
an organised screening programme, BreastScreen NSW (Estoesta
et al, 2000; Productivity Commission, 2002), which began in 1991
and reached a steady state between 1995 and 2000. The numbers of
bilateral mammograms reimbursed by the national health
insurance scheme, Medicare, were also available for 1995–99
(http://www.hic.gov.au/providers/health_statistics/statistical_repor-
ting/medicare.htm). These mammograms would include an un-
known but not high proportion of mammograms that were
primarily diagnostic. BreastScreen and Medicare account for most
of the screening mammography in Australia.
Analyses
Incidence rates and 95% confidence intervals (CIs) (Dobson et al,
1991) were calculated in 5- (DCIS) or 10-year (mammography) age
groups and age-standardised to the World population. The annual
percentage changes in rates were estimated in negative binomial
models with terms for age group and year of diagnosis.
Cases were allocated to urban or rural areas using BreastScreen’s
classification (Estoesta et al, 2000) and to five socioeconomic (SES)
groups (Australian Bureau of Statistics, 1998), and variation
among them tested in Poisson regression models.
The heterogeneity of DCIS distributions by size and grade
among age groups and type of architecture among years of
diagnosis was evaluated by standard w
2 tests. Age, grade,
architecture, multifocality and presence of necrosis were examined
as predictors of size (o2cm, 2þ cm) in logistic regression models
that included year of diagnosis; the additional effects of urban or
rural residence and SES of the women were also examined.
RESULTS
Incidence
In 1995–2000, 2109 NSW women were notified with DCIS. More
than half (54%) were 50–69 years of age, the target age group for
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(32.3 per 100000) (Table 1).
Incidence at all ages increased from 1995 (6.8 per 100000) to
2000 (8.9 per 100000) (annual average 5.5%, 95% CI 2.5–8.6),
mostly between 1996 and 1997 (39% increase) and in women 50–
69 years of age (48% increase 1996–1997) (Figure 1). Ductal
carcinoma in situ rates were higher in 1998–2000 than 1995–1997
in every age group, but did not continue to increase except,
perhaps, in women 70þ years of age.
The incidence of DCIS was about 25% higher in urban than rural
areas of NSW (Po0.001) and increased strongly with increasing
socio-economic status in Sydney (Po0.001, Table 1), but not other
areas of the State (P¼0.09). BreastScreen NSW detected 65% of
incident DCIS, with higher proportions in women older than 50
years.
Screening
BreastScreen and Medicare screened 265.1 per 1000 women 40
years of age and older in 1995 and 284.6 in 1999; all the increase
was in BreastScreen. BreastScreen screened twice as many women
50–69 years of age (269.2 per 1000) as women 40–49 (122.4) and
70þ years (120.1) (Figure 2); Medicare screening rates in the two
younger age groups were nearly equal. There was little difference
in the screening rates between urban (189.0 per 1000) and rural
(186.6) areas.
The numbers of DCIS detected were strongly correlated with the
numbers of women screened by BreastScreen in 1995–2000
(R¼0.83, Po0.001). There was a weaker correlation between
Medicare reimbursed mammograms and DCIS not detected by
BreastScreen in 1995–1999 (R¼0.64, P¼0.002).
Pathology information
Pathology reports were available for all but two cases of DCIS,
mainly from excision or re-excision specimens (73%) and
mastectomies (24%). Size was reported in 76%, grade in 89%
(both in 69%), presence or absence of necrosis in 63%, architecture
Table 1 Incidence of ductal carcinoma in situ of the breast in NSW
women in 1995–2000 by age, urban or rural residence and socioeconomic
status
Number Rate
a 95% CI
All NSW women 2109 8.6 8.2–9.0
Age group
20–39 91 1.4 1.1–1.7
40–49 458 17.3 15.7–19.0
50–59 634 31.8 29.4–34.4
60–69 495 32.8 29.9–35.8
70–79 354 28.8 25.8–32.0
80+ 77 10.6 8.4–13.3
50–69 1129 32.2 30.4–34.2
70+ 431 24.2 21.9–26.7
Urban & rural area
All areas 2100 8.5 8.2–8.9
Urban 1712 9.0 8.6–9.4
Rural 388 7.1 6.3–7.8
Po0.001
b
Socioeconomic status (Sydney Statistical Division only)
All areas 1369 9.2 8.7–9.7
1 lowest 205 7.2 6.2–8.2
2 197 7.5 6.4–8.6
3 226 8.5 7.4–9.8
4 342 10.9 9.7–12.1
5 highest 399 11.2 10.1–12.4
Po0.001
c
aRates are per 100000 women age-standardised to the World population.
bw
2 test
for difference in rates between urban and rural (metro vs non-metro) – Poisson
regression model.
cP-value for heterogeneity and trend o0.001.
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Figure 1 Trends in incidence of DCIS by age group in NSW women
from 1995 to 2000. Rates were standardised by 5-year age intervals within
broad age groups, using the World standard population.
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Figure 2 Mammogram rates in NSW women by age group – age-standardised in 10-year age groups to the World population.
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items. The width of margins was reported in only 41%. All these
items except the width of margins were appreciably more complete
in 1998–2000 than in 1995–97.
More than half (54%) the DCIS diagnosed in 1995–2000 were
high grade and 39% were 2cm or larger (Table 2). More DCIS were
high grade at 20–39 and 50–69 years (57%) than at other ages
(50%) (P¼0.02) and a higher proportion were 2þ cm at 20–39
(53%) than 40 years and older (38%) (P¼0.01). Size, however, was
not stated for more DCIS at 20–39 years (34%) than other ages
(24%).
Most (65%) of the DCIS were described as cribriform or solid, or
a mixture in which these two types predominated. Fewer were
identified as comedocarcinoma (10%) in 1998–2000 than in 1995–
1997 (26%) and more as a mixture of types (45% compared with
23%; P for difference between the two periods o0.001). High-
grade DCIS were distributed across all types (mixed 32%,
comedocarcinoma 27%, other specific types 21%, no specific type
20%). Most of the 2þ cm DCIS were mixed (45%) or other specific
types (27%) and few were comedocarcinoma (18%) or no specific
type (9%).
Age, grade, architecture and multifocality were significant
independent predictors of DCIS 2þ cm in size in a logistic
regression model (Table 3). Two-fold higher odds of having
2þ cm DCIS appeared to lie with a young age (20–39 years), with
high grade and with multifocal lesions. The excess risks of 2þ cm
DCIS also lay with mixed types of architecture (OR 1.5) compared
to comedocarcinoma and diagnosis in 1996 (OR 1.7), while a
report that did not mention necrosis was associated with lower
odds (OR 0.7) of a larger DCIS. Otherwise, there was no evident
trend across these variables. Neither place of residence (urban or
rural) nor SES was significantly predictive of 2þ cm DCIS or
appreciably affected the above odds ratios when added to the
model.
DISCUSSION
The main strengths of this study are its population base, detail and
recency. Population-based registration of DCIS in NSW began 2
years before the first year of our study, and the study’s first year
coincided with that of complete population coverage by BreastSc-
reen. Its main weakness is lack of linkage between the data sources
(BreastScreen, Medicare and the Cancer Registry), without which
we cannot fully describe the contribution of screening to the
occurrence and outcomes of DCIS.
Other countries have observed increasing incidence of DCIS,
sometimes three- to four-fold, with increasing mammographic
screening (Ernster et al, 1996; Levi et al, 1997; Zheng et al, 1997;
Barchielli et al, 1999; Blanks et al, 2000). This increase has stopped
in NSW and we would expect further increases only with growth in
BreastScreen participation beyond 53–54% in 1998–2000 (Estoes-
ta et al, 2000; Productivity Commission, 2002) or resurgence in
mammographic screening reimbursed by Medicare.
We observed a higher proportion of high-grade lesions (54%)
than in Sweden (43%) and Switzerland (46%) in the early 1990s,
but similar to that, 55%, in an Australia-wide sample survey (Levi
et al, 1997; Wa ¨rnberg et al, 1999; Shugg et al, 2002). This apparent
difference between Australia and these European countries may be
real and due to the extent of high-grade disease, or caused by
differences in the reporting of grade. It could reflect, too,
differences in mammography rates since high-grade DCIS is said
to show abnormal mammographic features more frequently than
low grade (Evans et al, 2001).
We found that age, high-grade lesions, mixed architecture and
multifocality significantly and independently predicted DCIS
larger than 2cm diameter. That women 20–39 years of age were
more likely to have 2þ cm diameter DCIS (average 28mm in
multivariate models in this study) than older women (average
18mm) is probably due to their lower mammography rate. That
high-grade lesions were larger probably reflects a correlation with
higher growth rate (1.8mm per year low grade, 4.2mm
Table 3 Association of 2+cm DCIS with year of diagnosis, age, size,
grade, necrosis and multifocality in NSW women in 1995–2000
o2cm 2+cm OR (95% CI) P-value
Year of diagnosis
1995 112 46 1
1996 120 89 1.66 (1.05–2.64)
1997 190 106 1.19 (0.76–1.86)
1998 209 105 0.74 (0.47–1.18)
1999 159 129 1.25 (0.78–1.98)
2000 184 135 1.05 (0.66–1.67) 0.002
Age group
20–39 28 32 1.87 (1.07–3.27)
40–49 210 132 1.07 (0.82–1.40)
50–69 556 316 1
70+ 180 130 1.39 (1.05–1.84) 0.03
Grade
Low 156 58 1
Medium 275 147 1.27 (0.86–1.87)
High 442 365 2.14 (1.46–3.14)
Not given 101 40 1.3 (0.78–2.17) o0.0001
Necrosis
Present 538 411 1
Absent 72 45 0.94 (0.61–1.46)
Not given 364 154 0.65 (0.49–0.86) 0.006
Architecture
Comedocarcinoma 163 112 1
Mixed types
a 309 278 1.46 (1.05–2.04)
Other specified types
b 326 166 0.89 (0.63–1.26)
Type unspecified 176 54 0.49 (0.32–0.73) o0.0001
Multifocal
No 737 377 1
Yes 237 233 1.92 (1.52–2.43) o0.0001
aMixed types: cribriform with solid or papillary architecture or both (64% of mixed
types); comedocarcinoma and other type (18%); other (18%).
bOther specified types:
cribriform (41%), solid (40%), micropapillary (13%) and intracystic papillary carcinoma
in situ (6%).
Table 2 Number, percent and rate of DCIS by grade and size in NSW in
1995–2000
Number % Rate
a 95% CI
Grade
Low 313 16.7 1.2 (1.1–1.4)
Intermediate 542 29.0 2.2 (2.0–2.4)
High 1015 54.3 4.2 (3.9–4.5)
Total 1870 100.0 8.6 (8.2–9.0)
Unknown 239 0.9 (0.8–1.1)
Size
0–0.9cm 505 31.5 2.1 (1.9–2.3)
1–1.9cm 480 30.0 2.0 (1.8–2.2)
2–2.9cm 278 17.4 1.1 (1.0–1.3)
3+cm 339 21.2 1.4 (1.2–1.5)
Total 1602 100.0 8.6 (8.2–9.0)
Unknown 507 2.0 (1.9–2.2)
aRates are per 100000 women age-standardised to the World population.
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particularly since they may also be more readily detectable
mammographically (Evans et al, 2001). The Van Nuys prognostic
index has shown a parallel increase of size with grade although
patients treated with mastectomy, and thus probably the larger
lesions, were excluded (Silverstein, 2003). Another series showed a
step down from 20mm diameter poorly differentiated DCIS to
15mm for all other grades (Solin et al, 1991). Our study appears to
give the first population-based estimates: the average size increased
steadily from 16mm for low grade to 20mm for intermediate and
27mm for high-grade DCIS in the multivariate models of Table 3.
Variation in growth rate might also underlie the significant,
independent association of architecture with tumour size.
The pathology reports from 1998 to 2000 reported DCIS
substantially more completely than did earlier Australian reports
(Kricker et al, 1999; Giles et al, 2001; Shugg et al, 2002). The
Australian Cancer Network addressed pathology reporting of DCIS
with extensive consultation among pathologists in the mid-1990s
and published recommendations in 1997 (Australian Cancer
Network Working Party, 1997) and 2001 (Australian Cancer
Network Working Party, 2001). Their adoption by pathologists
may explain the more complete reporting we observed.
Increasing incidence of DCIS is an outcome of mammographic
screening for breast cancer. The high proportion of high-grade
lesions we have observed suggests that its detection could
contribute to reducing breast cancer mortality. If it does not, the
high frequency of DCIS in association with screening may be
source of unnecessary morbidity and cost. More research is needed
into the costs and benefits of detection of DCIS in breast cancer
screening.
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